These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25953188)

  • 41. Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray.
    Zimenkov DV; Kulagina EV; Antonova OV; Zhuravlev VY; Gryadunov DA
    J Antimicrob Chemother; 2016 Jun; 71(6):1520-31. PubMed ID: 26929267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficient differentiation of Mycobacterium tuberculosis strains of the W-Beijing family from Russia using highly polymorphic VNTR loci.
    Surikova OV; Voitech DS; Kuzmicheva G; Tatkov SI; Mokrousov IV; Narvskaya OV; Rot MA; van Soolingen D; Filipenko ML
    Eur J Epidemiol; 2005; 20(11):963-74. PubMed ID: 16284875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.
    Sweetline Anne N; Ronald BSM; Senthil Kumar TMA; Thangavelu A
    Tuberculosis (Edinb); 2019 Jan; 114():113-118. PubMed ID: 30711149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Draft Genome Sequence of Mycobacterium tuberculosis Clinical Strain W06, a Prevalent Beijing Genotype Isolated in Taiwan.
    Liao YC; Liu TT; Chang JR; Chen YY; Lin HH; Hsu CH; Lin CY; Lo YC; Dou HY
    Genome Announc; 2015 Dec; 3(6):. PubMed ID: 26659689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon.
    Panossian B; Salloum T; Araj GF; Khazen G; Tokajian S
    BMC Infect Dis; 2018 Dec; 18(1):710. PubMed ID: 30594126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-resistant Mycobacterium tuberculosis in Korean isolates.
    Carpenter JL; Covelli HD; Avant ME; McAllister CK; Higbee JW; Ognibene AJ
    Am Rev Respir Dis; 1982 Dec; 126(6):1092-5. PubMed ID: 6185025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The viability and protein expression of Beijing/W lineage Mycobacterium tuberculosis circulating in Xinjiang, China.
    Li F; Li H; Zuo WZ; Mi L; Wang X; Wang Y; Wang H; Shen A; Cao S; Yuan L
    Curr Microbiol; 2015 May; 70(5):735-44. PubMed ID: 25656263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A complete high-quality MinION nanopore assembly of an extensively drug-resistant Mycobacterium tuberculosis Beijing lineage strain identifies novel variation in repetitive PE/PPE gene regions.
    Bainomugisa A; Duarte T; Lavu E; Pandey S; Coulter C; Marais BJ; Coin LM
    Microb Genom; 2018 Jul; 4(7):. PubMed ID: 29906261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrospective Analysis of Archived Pyrazinamide Resistant
    Wanzala SI; Nakavuma J; Travis D; Kia P; Ogwang S; Waters WR; Thacker T; Johnson T; Hadi SA; Sreevatsan S
    Microorganisms; 2019 Jul; 7(8):. PubMed ID: 31362370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic Analysis Identifies Mutations Concerning Drug-Resistance and Beijing Genotype in Multidrug-Resistant
    Wan L; Liu H; Li M; Jiang Y; Zhao X; Liu Z; Wan K; Li G; Guan CX
    Front Microbiol; 2020; 11():1444. PubMed ID: 32760357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Draft Genome Sequence of a Multidrug-Resistant New Zealand Isolate of Mycobacterium tuberculosis Lineage 3.
    Mac Aogáin M; Johari BM; Bower JE; O'Toole RF
    Genome Announc; 2014 Oct; 2(5):. PubMed ID: 25323711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the beijing strain family.
    Drobniewski F; Balabanova Y; Ruddy M; Weldon L; Jeltkova K; Brown T; Malomanova N; Elizarova E; Melentyey A; Mutovkin E; Zhakharova S; Fedorin I
    Emerg Infect Dis; 2002 Nov; 8(11):1320-6. PubMed ID: 12453364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Molecular epidemiologic study on
    Huang XC; Guo HX; Wu ZH; Guo CX; Wei WJ; Li HC; Sun Q; Zhang CC; Li ZY; Chen T; Zhong Q; Zhou L
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 May; 40(5):334-338. PubMed ID: 28482417
    [No Abstract]   [Full Text] [Related]  

  • 59. Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using
    Genestet C; Ader F; Pichat C; Lina G; Dumitrescu O; Goutelle S
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families.
    Kasule GW; Kateete DP; Joloba ML
    BMC Infect Dis; 2016 Apr; 16():173. PubMed ID: 27097724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.